These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28650401)

  • 1. Progressive Brain Atrophy Despite Persistent Viral Suppression in HIV Patients Older Than 60 Years.
    Clifford KM; Samboju V; Cobigo Y; Milanini B; Marx GA; Hellmuth JM; Rosen HJ; Kramer JH; Allen IE; Valcour VG
    J Acquir Immune Defic Syndr; 2017 Nov; 76(3):289-297. PubMed ID: 28650401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.
    Sanford R; Fernandez Cruz AL; Scott SC; Mayo NE; Fellows LK; Ances BM; Collins DL
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):563-570. PubMed ID: 28129254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular Disease Correlates With Longitudinal Brain Atrophy in Virally Suppressed Older People Living With HIV.
    Samboju V; Cobigo Y; Paul R; Naasan G; Hillis M; Tsuei T; Javandel S; Valcour V; Milanini B
    J Acquir Immune Defic Syndr; 2021 Aug; 87(4):1079-1085. PubMed ID: 34153014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.
    Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA
    AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nadir CD4 count and duration of human immunodeficiency virus infection on brain volumes in the highly active antiretroviral therapy era.
    Cohen RA; Harezlak J; Schifitto G; Hana G; Clark U; Gongvatana A; Paul R; Taylor M; Thompson P; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B
    J Neurovirol; 2010 Feb; 16(1):25-32. PubMed ID: 20113183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.
    Tate DF; Sampat M; Harezlak J; Fiecas M; Hogan J; Dewey J; McCaffrey D; Branson D; Russell T; Conley J; Taylor M; Schifitto G; Zhong J; Daar ES; Alger J; Brown M; Singer E; Campbell T; McMahon D; Tso Y; Matesan J; Letendre S; Paulose S; Gaugh M; Tripoli C; Yiannoutsos C; Bigler ED; Cohen RA; Guttmann CR; Navia B;
    J Neurovirol; 2011 Aug; 17(4):368-79. PubMed ID: 21556960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive brain atrophy in chronically infected and treated HIV+ individuals.
    Nir TM; Jahanshad N; Ching CRK; Cohen RA; Harezlak J; Schifitto G; Lam HY; Hua X; Zhong J; Zhu T; Taylor MJ; Campbell TB; Daar ES; Singer EJ; Alger JR; Thompson PM; Navia BA;
    J Neurovirol; 2019 Jun; 25(3):342-353. PubMed ID: 30767174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.
    Heaps JM; Sithinamsuwan P; Paul R; Lerdlum S; Pothisri M; Clifford D; Tipsuk S; Catella S; Busovaca E; Fletcher JL; Raudabaugh B; Ratto-Kim S; Valcour V; Ananworanich J;
    J Neurovirol; 2015 Apr; 21(2):105-12. PubMed ID: 25604494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive disorders in HIV-infected patients: are they HIV-related?
    Bonnet F; Amieva H; Marquant F; Bernard C; Bruyand M; Dauchy FA; Mercié P; Greib C; Richert L; Neau D; Catheline G; Dehail P; Dabis F; Morlat P; Dartigues JF; Chêne G;
    AIDS; 2013 Jan; 27(3):391-400. PubMed ID: 23079813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApoE ε4 Is Associated With Cognition, Brain Integrity, and Atrophy in HIV Over Age 60.
    Wendelken LA; Jahanshad N; Rosen HJ; Busovaca E; Allen I; Coppola G; Adams C; Rankin KP; Milanini B; Clifford K; Wojta K; Nir TM; Gutman BA; Thompson PM; Valcour V
    J Acquir Immune Defic Syndr; 2016 Dec; 73(4):426-432. PubMed ID: 27228100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent effects of HIV, aging, and HAART on brain volumetric measures.
    Ances BM; Ortega M; Vaida F; Heaps J; Paul R
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):469-77. PubMed ID: 22269799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and liver pathology, amyloid deposition, and interferon responses among older HIV-positive patients in the late HAART era.
    Solomon IH; De Girolami U; Chettimada S; Misra V; Singer EJ; Gabuzda D
    BMC Infect Dis; 2017 Feb; 17(1):151. PubMed ID: 28212619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
    Sanford R; Fellows LK; Ances BM; Collins DL
    JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the brain in younger and older asymptomatic HIV-1 men: frontal volume changes in the absence of other cortical or diffusion tensor abnormalities.
    Towgood KJ; Pitkanen M; Kulasegaram R; Fradera A; Kumar A; Soni S; Sibtain NA; Reed L; Bradbeer C; Barker GJ; Kopelman MD
    Cortex; 2012 Feb; 48(2):230-41. PubMed ID: 21481856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
    Ulfhammer G; Edén A; Mellgren Å; Fuchs D; Zetterberg H; Hagberg L; Nilsson S; Yilmaz A; Gisslén M
    AIDS; 2018 Sep; 32(15):2171-2178. PubMed ID: 30005007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging correlates of the blood-brain barrier disruption in HIV-associated neurocognitive disorder and therapeutic implications.
    Chaganti J; Marripudi K; Staub LP; Rae CD; Gates TM; Moffat KJ; Brew BJ
    AIDS; 2019 Oct; 33(12):1843-1852. PubMed ID: 31274535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. HIV Neurobehavioral Research Center Group.
    Stout JC; Ellis RJ; Jernigan TL; Archibald SL; Abramson I; Wolfson T; McCutchan JA; Wallace MR; Atkinson JH; Grant I
    Arch Neurol; 1998 Feb; 55(2):161-8. PubMed ID: 9482357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reductions in Gray Matter Linked to Epigenetic HIV-Associated Accelerated Aging.
    Lew BJ; Schantell MD; O'Neill J; Morsey B; Wang T; Ideker T; Swindells S; Fox HS; Wilson TW
    Cereb Cortex; 2021 Jul; 31(8):3752-3763. PubMed ID: 33822880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.
    Sanford R; Ances BM; Meyerhoff DJ; Price RW; Fuchs D; Zetterberg H; Spudich S; Collins DL
    Clin Infect Dis; 2018 Nov; 67(11):1697-1704. PubMed ID: 29697762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.